204 related articles for article (PubMed ID: 22057257)
21. CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.
Tarique AA; Sly PD; Holt PG; Bosco A; Ware RS; Logan J; Bell SC; Wainwright CE; Fantino E
J Cyst Fibros; 2017 Jul; 16(4):475-482. PubMed ID: 28428011
[TBL] [Abstract][Full Text] [Related]
22. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
Zhang S; Shrestha CL; Kopp BT
Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
[TBL] [Abstract][Full Text] [Related]
23. Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).
Moss RB; Bocian RC; Hsu YP; Dong YJ; Kemna M; Wei T; Gardner P
Clin Exp Immunol; 1996 Nov; 106(2):374-88. PubMed ID: 8918588
[TBL] [Abstract][Full Text] [Related]
24. Current concepts of immune dysregulation in cystic fibrosis.
Rieber N; Hector A; Carevic M; Hartl D
Int J Biochem Cell Biol; 2014 Jul; 52():108-12. PubMed ID: 24495876
[TBL] [Abstract][Full Text] [Related]
25. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
John G; Yildirim AO; Rubin BK; Gruenert DC; Henke MO
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):424-31. PubMed ID: 19502387
[TBL] [Abstract][Full Text] [Related]
26. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
Bruscia EM; Bonfield TL
J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
[TBL] [Abstract][Full Text] [Related]
27. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
28. Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
Sorio C; Montresor A; Bolomini-Vittori M; Caldrer S; Rossi B; Dusi S; Angiari S; Johansson JE; Vezzalini M; Leal T; Calcaterra E; Assael BM; Melotti P; Laudanna C
Am J Respir Crit Care Med; 2016 May; 193(10):1123-33. PubMed ID: 26694899
[TBL] [Abstract][Full Text] [Related]
29. Peripheral decrease and pulmonary homing of CD4+CD45RO+ helper memory T cells in cystic fibrosis.
Häusler M; Schweizer K; Biesterfel S; Opladen T; Heimann G
Respir Med; 2002 Feb; 96(2):87-94. PubMed ID: 11860174
[TBL] [Abstract][Full Text] [Related]
30. Relationships among CFTR expression, HCO3- secretion, and host defense may inform gene- and cell-based cystic fibrosis therapies.
Shah VS; Ernst S; Tang XX; Karp PH; Parker CP; Ostedgaard LS; Welsh MJ
Proc Natl Acad Sci U S A; 2016 May; 113(19):5382-7. PubMed ID: 27114540
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
Bodas M; Mazur S; Min T; Vij N
Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.
Robledo-Avila FH; Ruiz-Rosado JD; Brockman KL; Kopp BT; Amer AO; McCoy K; Bakaletz LO; Partida-Sanchez S
J Immunol; 2018 Oct; 201(7):2016-2027. PubMed ID: 30120123
[TBL] [Abstract][Full Text] [Related]
33. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients.
Bensalem N; Ventura AP; Vallée B; Lipecka J; Tondelier D; Davezac N; Dos Santos A; Perretti M; Fajac A; Sermet-Gaudelus I; Renouil M; Lesure JF; Halgand F; Laprévote O; Edelman A
Mol Cell Proteomics; 2005 Oct; 4(10):1591-601. PubMed ID: 16014420
[TBL] [Abstract][Full Text] [Related]
35. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
Jaganathan D; Bruscia EM; Kopp BT
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
[TBL] [Abstract][Full Text] [Related]
36. Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.
Bonfield TL; Hodges CA; Cotton CU; Drumm ML
J Leukoc Biol; 2012 Nov; 92(5):1111-22. PubMed ID: 22859830
[TBL] [Abstract][Full Text] [Related]
37. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
38. The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.
Bodas M; Vij N
Discov Med; 2010 Apr; 9(47):346-56. PubMed ID: 20423679
[TBL] [Abstract][Full Text] [Related]
39. Innate and Adaptive Immunity in Cystic Fibrosis.
Bruscia EM; Bonfield TL
Clin Chest Med; 2016 Mar; 37(1):17-29. PubMed ID: 26857765
[TBL] [Abstract][Full Text] [Related]
40. Detection of CFTR protein in human leukocytes by flow cytometry.
Johansson J; Vezzalini M; Verzè G; Caldrer S; Bolognin S; Buffelli M; Bellisola G; Tridello G; Assael BM; Melotti P; Sorio C
Cytometry A; 2014 Jul; 85(7):611-20. PubMed ID: 24623386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
